Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Boston Scientific Corp (BSX)  
$76.31 0.12 (0.16%) as of 4:30 Tue 6/18


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 1,430,000,000
Market Cap: 109.12(B)
Last Volume: 5,365,633 Avg Vol: 8,385,378
52 Week Range: $48.64 - $77.42
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:

    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  297
Guru Rank Value     : 4.1
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 304,513 503,645 1,002,990 2,126,174
Total Sell Value $22,679,618 $34,760,114 $61,125,774 $111,248,213
Total People Sold 9 10 11 13
Total Sell Transactions 14 26 44 80
End Date 2024-03-21 2023-12-19 2023-06-20 2022-06-20

   
Records found: 1824
  Page 45 of 73  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Phalen Michael P. SVP & President, Endoscopy   •       –      –    2010-02-12 4 OE $0.00 $0 D/D 3,274 22,586     -
   Onuscheck John Michael SVP & Pres-Neuromodulation   •       –      –    2010-02-12 4 D $7.39 $12,659 D/D (1,713) 21,943     -
   Onuscheck John Michael SVP & Pres-Neuromodulation   •       –      –    2010-02-12 4 OE $0.00 $0 D/D 3,993 23,656     -
   Pedersen John B. Pres,Uro & Womens Health   •       –      –    2010-02-12 4 D $7.39 $2,801 D/D (379) 619     -
   Pedersen John B. Pres,Uro & Womens Health   •       –      –    2010-02-12 4 OE $0.00 $0 D/D 998 998     -
   Leno Sam R CFO & EVP Finance & IS   •       –      –    2010-02-12 4 OE $0.00 $0 D/D 10,982 227,464     -
   Burns Brian R SVP - Global Quality   •       –      –    2010-02-12 4 D $7.39 $25,362 D/D (3,432) 37,700     -
   Burns Brian R SVP - Global Quality   •       –      –    2010-02-12 4 OE $0.00 $0 D/D 10,806 41,132     -
   Paul Donovan SVP, Corporate Communications   •       –      –    2010-02-12 4 D $7.39 $24,424 D/D (3,305) 33,103     -
   Paul Donovan SVP, Corporate Communications   •       –      –    2010-02-12 4 OE $0.00 $0 D/D 10,406 36,408     -
   Fitzgerald Joseph Michael SVP & President, Endovascular   •       –      –    2010-02-12 4 D $7.39 $5,742 D/D (777) 30,465     -
   Fitzgerald Joseph Michael SVP & President, Endovascular   •       –      –    2010-02-12 4 OE $0.00 $0 D/D 1,996 31,242     -
   Moreci Stephen F SVP, Global Sales Operations   •       –      –    2010-02-12 4 D $7.39 $8,402 D/D (1,137) 21,177     -
   Moreci Stephen F SVP, Global Sales Operations   •       –      –    2010-02-12 4 OE $0.00 $0 D/D 2,995 22,314     -
   Colen Fred EVP & Chief Technology Officer   •       –      –    2010-02-12 4 D $7.39 $48,966 D/D (6,626) 62,815     -
   Colen Fred EVP & Chief Technology Officer   •       –      –    2010-02-12 4 OE $0.00 $0 D/D 19,468 69,441     -
   Kucheman William EVP, Cardiology   •       –      –    2010-02-12 4 D $7.39 $19,310 D/D (2,613) 42,366     -
   Kucheman William EVP, Cardiology   •       –      –    2010-02-12 4 OE $0.00 $0 D/D 7,986 44,979     -
   Gilbert James EVP, Strategy & Business Dev   •       –      –    2010-02-12 4 D $7.39 $11,203 D/D (1,516) 65,393     -
   Gilbert James EVP, Strategy & Business Dev   •       –      –    2010-02-12 4 OE $0.00 $0 D/D 3,993 66,909     -
   Pucel Kenneth EVP, Global Operations   •       –      –    2010-02-12 4 D $7.39 $30,927 D/D (4,185) 59,485     -
   Pucel Kenneth EVP, Global Operations   •       –      –    2010-02-12 4 OE $0.00 $0 D/D 13,178 63,670     -
   Lance Jean Fitterer Chief Compliance Officer   •       –      –    2010-02-12 4 D $7.39 $9,186 D/D (1,243) 50,068     -
   Lance Jean Fitterer Chief Compliance Officer   •       –      –    2010-02-12 4 OE $0.00 $0 D/D 3,194 51,311     -
   Mcfaul David W SVP, International   •       –      –    2010-02-12 4 D $7.39 $7,841 D/D (1,061) 41,426     -

  1824 Records found
  Previous  40  41  42  43  44  45  46  47  48  49  Next   
  Page 45 of 73
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed